Sfoglia per RIVISTA
FRONTIERS IN ONCOLOGY
Collezione AOU San Luigi di Orbassano

  

Items : 9

Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study. in Frontiers in oncology / Front Oncol. 2024 Jul 9;14:1436588. doi: 10.3389/fonc.2024.1436588. eCollection 2024.

2024
AOU San Luigi di Orbassano

Sposito M; Belluomini L; Nocini R; Insolda J; Scaglione IM; Menis J; Simbolo M; Lugini A; Buzzacchino F; Verderame F; Spinnato F; Aprile G; Calvetti L; Occhipinti M; Marinelli D; Veccia A; Lombardo F; Soto Parra HJ; Ferraù F; Savastano C; Porta C; Pradelli L; Sicari E; Castellani S; Malapelle U; Novello S; Bria E; Pilotto S; Milella M; et alii...

Surgical and oncological management of renal medullary carcinoma in a young patient: a case report. in Frontiers in oncology / Front Oncol. 2023 May 2;13:1073728. doi: 10.3389/fonc.2023.1073728. eCollection 2023.

2023
AOU San Luigi di Orbassano

Courcier J; De La Taille A; Bertolo R; Amparore D; Erdem S; Kara O; Marchioni M; Pavan N; Roussel E; Mamodaly M; Campi R; Ingels A;

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC). in Frontiers in oncology / Front Oncol. 2023 Mar 29;13:1113246. doi: 10.3389/fonc.2023.1113246. eCollection 2023.

2023
AOU San Luigi di Orbassano

Meagher MF; Mir MC; Minervini A; Kriegmair M; Heck M; Porpiglia F; Van Bruwaene S; Linares E; Hevia V; D'Anna M; Veccia A; Roussel E; Claps F; Palumbo C; Marchioni M; Afari J; Saitta C; Liu F; Rubio J; Campi R; Mari A; Amiel T; Checcucci E; Musquera M; Guruli G; Pavan N; Albersen M; Antonelli A; Klatte T; et alii...

DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination. in Frontiers in oncology / Front Oncol. 2022 Aug 30;12:844250. doi: 10.3389/fonc.2022.844250. eCollection 2022.

2022
AOU San Luigi di Orbassano

Brusco S; Pisacane A; Maldi E; Sarotto I; Capozzi F; Lano C; Isella C; Crisafulli G; Aglietta M; Dei Tos AP; Sbaraglia M; Sangiolo D; D'Ambrosio L; Bardelli A; Pignochino Y; Grignani G; Merlini A; Centomo ML; Ferrero G; Chiabotto G; Miglio U; Berrino E; Giordano G;

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA). in Frontiers in oncology / Front Oncol. 2022 Oct 3;12:992137. doi: 10.3389/fonc.2022.992137. eCollection 2022.

2022
AOU Città della Salute di Torino
AOU Alessandria
AOU San Luigi di Orbassano

Hernández-Rivas JÁ; Pagano L; Marchetti M; Cuccaro A; Calbacho M; Giordano A; Prezioso L; Cornely OA; Nunes-Rodrigues R; Navrátil M; Karlsson LK; Batini? J; Nordlander A; De Jonge N; Adži?-Vuki?evi? T; Mladenovi? M; Hanakova M; Zambrotta GPM; Rá?il Z; Hoenigl M; Schönlein M; Meers S; Lahmer T; Martín-Pérez S; Dávila-Vals J; Van Praet J; Samarkos M; Bilgin YM; Cabirta A; et alii...

Dosing Strategies for Improving the Risk-Benefit Profile of Ponatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase. in Frontiers in oncology / Front Oncol. 2021 Mar 16;11:642005. doi: 10.3389/fonc.2021.642005. eCollection 2021.

2021
AOU San Luigi di Orbassano

Breccia M; Saglio G; Rosti G; Castagnetti F; Pane F;

A Fully Automatic Artificial Intelligence System Able to Detect and Characterize Prostate Cancer Using Multiparametric MRI: Multicenter and Multi-Scanner Validation. in Frontiers in oncology / Front Oncol. 2021 Oct 1;11:718155. doi: 10.3389/fonc.2021.718155. eCollection 2021.

2021
ASL Cuneo 2
AOU San Luigi di Orbassano

Russo F; Regge D; Veltri A; Manfredi M; De Pascale A; Porpiglia F; Bosco M; Calandri M; Bollito E; Stranieri G; Defeudis A; Mazzetti S; Giannini V;

Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy. in Frontiers in oncology / Front Oncol. 2021 May 26;11:638689. doi: 10.3389/fonc.2021.638689. eCollection 2021.

2021
AOU San Luigi di Orbassano

Borghi L; Rosti G; Maggi A; Breccia M; Di Bona E; Iurlo A; La Barba G; Sportoletti P; Albano F; Galimberti S; Rivellini F; Cambrin GR; Capodanno I; Cuneo A; Bonifacio M; Sica S; Arcaini L; Capochiani E; Minotto C; Ciceri F; Crugnola M; Di Caprio L; Supekar S; Elena C; Baccarani M; Vegni E;

Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer. in Frontiers in oncology / Front Oncol. 2018 Jul 27;8:278. doi: 10.3389/fonc.2018.00278. eCollection 2018.

2018
ASL Cuneo 1
AOU San Luigi di Orbassano

Novello S; Vavalà T; Morelli AM; Turkaj A;